Fertility and Sterility/LinkedIn
Apr 25, 2026, 06:21
Silymarin Protects Male Fertility During Chemotherapy – Fertility and Sterility
Fertility and Sterility shared a post on LinkedIn:
“In F and S Science:
Silymarin mitigates chemotherapy-induced testicular injury by enhancing antioxidant defense and preserving reproductive function in male mice.”
Title: Silymarin Mitigates Chemotherapy Induced Testicular Injury by Enhancing Antioxidant Defense and Preserving Reproductive Function in Male Mice
Autors: Dhafer Jawada Abdulrhman Khalifab Hayder Abedd
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 18, 2026, 11:38Inshirah Sgayer: Happy to Share Our New Publication on Unstable Fetal Lie
-
May 18, 2026, 11:27Join Us for Insightful Conversations on FRMC 2026 – Center for Human Reproduction
-
May 18, 2026, 11:19Devyanshi Dixit: PCOS and Hormonal Disorders, Advancing Precision Care in Women’s Endocrine Health
-
May 18, 2026, 11:17ASRM Responds to Supreme Court Mifepristone Decision – ASRM
-
May 18, 2026, 11:12Nibhash Kumar: Can an Intact Acrosome During ICSI Contribute to Fertilization Failure?
-
May 18, 2026, 11:05Hope Alicia: Fertility Show 2026 Highlights the Importance of Patient Support and Education
-
May 18, 2026, 11:02$10,000 Prize Announced for 2026 ASRM INNOVATE Pitch Tank Showcase – ASRM
-
May 18, 2026, 07:09Why “Just Keep Trying” is Bad Advice if You’re Under 38 with Unexplained Infertility – Fertility Plus
-
May 18, 2026, 06:37Sandro Esteves: “Merging Galaxies” at the POSEIDON and APHRODITE Conference